PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Isabelle Monsman

Cameco (Canada)

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · JOURNAL ARTICLE

Macrophage migration inhibitory factor is a potential therapeutic target for cisplatin induced peripheral neuropathy in breast cancer

Neuro-oncology Advances

Mechanistic preclinical study in mouse models proposing MIF as a therapeutic target; lacks clinical validation, hard endpoints, or translation to patient benefit.

Hypothesis-GeneratingBhadrapriya Sivakumar Macrophage Migration Inhibitory Factor Nishi Bamania

Study details

DesignPreclinical mechanistic study in mouse mode…

InterventionPharmacological inhibition of MIF using sma…

ComparatorUntreated CisIPN mice (control)

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support